HMS Stock Forecast, Price & News

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for HMS in the last year. There are currently 10 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" HMS stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HMSY, but not buy additional shares or sell existing shares.
View analyst ratings for HMS or view top-rated stocks.

Wall Street analysts have given HMS a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but HMS wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

HMS Holdings Corp. (NASDAQ:HMSY) announced its earnings results on Thursday, February, 25th. The business services provider reported $0.51 EPS for the quarter, topping the consensus estimate of $0.43 by $0.08. The business services provider had revenue of $194 million for the quarter, compared to analyst estimates of $201.64 million. HMS had a trailing twelve-month return on equity of 8.86% and a net margin of 8.51%. The company's revenue was up 18.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.27 EPS.
View HMS's earnings history.

11 brokerages have issued 1 year price objectives for HMS's stock. Their forecasts range from $33.00 to $37.00. On average, they expect HMS's share price to reach $35.00 in the next year. This suggests that the stock has a possible downside of 5.3%.
View analysts' price targets for HMS or view top-rated stocks among Wall Street analysts.

216 employees have rated HMS CEO Bill Lucia on Glassdoor.com. Bill Lucia has an approval rating of 91% among HMS's employees. This puts Bill Lucia in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to HMS include Cerner (CERN), Omnicell (OMCL), Allscripts Healthcare Solutions (MDRX), Cortexyme (CRTX), Vocera Communications (VCRA), HealthStream (HSTM), Computer Programs and Systems (CPSI), Athena Technology Acquisition (ATHN) and Mirage Energy (MRGE).
View all of HMSY's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other HMS investors own include Advanced Micro Devices (AMD), Visa (V), The Walt Disney (DIS), Netflix (NFLX), Cisco Systems (CSCO), General Electric (GE), Micron Technology (MU), NVIDIA (NVDA), AT&T (T) and Alibaba Group (BABA).

HMS trades on the NASDAQ under the ticker symbol "HMSY."

One share of HMSY stock can currently be purchased for approximately $36.98.

HMS has a market capitalization of $3.28 billion and generates $626.40 million in revenue each year. The business services provider earns $87.22 million in net income (profit) each year or $1.15 on an earnings per share basis.

HMS employs 3,100 workers across the globe.

The following companies are subsidiares of HMS: Eliza Corporation, Eliza Holding Corp, ElizaLive, Essette, HMS Care Analytics, Health Management Systems, HealthDataInsights, IntegriGuard, Permedion, and Reimbursement Services Group Inc.

HMS was founded in 1974.

The official website for HMS is www.hms.com.

HMS is headquartered at 5615 High Point Drive, Irving TX, 75038.

HMS's mailing address is 5615 High Point Drive, Irving TX, 75038. The business services provider can be reached via phone at 214-453-3000 or via email at [email protected]